(Q34084628)
Statements
1 reference
Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study (English)
1 reference
Appelberg BG
1 reference
Syvälahti EK
1 reference
Koskinen TE
1 reference
Mehtonen OP
1 reference
Muhonen TT
1 reference
Naukkarinen HH
1 reference
1 June 2001
1 reference
1 reference
62
1 reference
448-452
1 reference
Identifiers
1 reference